Quail J.M.,McGill University |
Quail J.M.,41 111 Research Drive |
Wolfson C.,McGill University |
Lippman A.,McGill University
Canadian Journal on Aging | Year: 2011
Community-dwelling seniors increasingly require physical assistance to perform the activities of daily living (ADL). To examine the possible association of this need with psychological distress, we conducted a prospective cohort study of community-dwelling people age 75 and older in Montreal, Canada. We report the results for women only (n = 530). Multivariable linear regression was used to examine the association between met and unmet need in instrumental ADL (IADL) and personal ADL (PADL) with concomitant psychological distress. Unmet IADL need was associated with elevated psychological distress [β = 0.42 (95% CI: 0.26, 0.60)], as was met IADL need [β = 0.19 (95% CI: 0.06, 0.33)], but not met and unmet PADL need. The full model explained 32.8 per cent of the total variance in psychological distress. Receiving assistance to meet IADL needs is associated with elevated psychological distress. Not receiving assistance, however, is associated with even greater distress. © 2011 Canadian Association on Gerontology.
Evans C.,University of Saskatchewan |
Marrie R.A.,University of Manitoba |
Zhu F.,University of British Columbia |
Leung S.,University of Manitoba |
And 5 more authors.
Multiple Sclerosis and Related Disorders | Year: 2016
Objective We aimed to estimate the prevalence and predictors of optimal adherence and persistence to the disease-modifying therapies (DMT) for multiple sclerosis (MS) in 3 Canadian provinces. Methods We used population-based administrative databases in British Columbia (BC), Saskatchewan, and Manitoba. All individuals receiving DMT (interferon-B-1b, interferon-B-1a, and glatiramer acetate) between 1-January-1996 and 31-December-2011 (BC), 31-March-2014 (Saskatchewan), or 31-March-2012 (Manitoba) were included. One-year adherence was estimated using the proportion of days covered (PDC). Persistence was defined as time to DMT discontinuation. Regression models were used to assess predictors of adherence and persistence; results were pooled using random effects meta-analysis. Results 4830 individuals were included. When results were combined, an estimated 76.4% (95% CI: 69.1-82.4%) of subjects exhibited optimal adherence (PDC ≥80%). Median time to discontinuation of the initial DMT was 1.9 years (95% CI: 1.6-2.1) in Manitoba, 2.8 years (95% CI: 2.5-3.0) in BC, and 4.0 years (95% CI: 3.5-4.6) in Saskatchewan. Age, sex and socioeconomic status were not associated with adherence or persistence. Individuals who had ≥4 physician visits during the year prior to the first DMT dispensation were more likely to exhibit optimal adherence compared to those with fewer (0-3) physician visits. Conclusions We observed adherence that is higher than what has been reported for other chronic diseases, and other non-population-based MS cohorts. Closer examination as to why adherence appears to be relatively better in MS and how adherence influences disease outcomes could contribute to our understanding of MS, and prove useful in the management of other chronic diseases. © 2016 The Authors. Published by Elsevier B.V.
Pinelle D.,University of Saskatchewan |
Pinelle D.,41 111 Research Drive |
Burbridge B.,University of Saskatchewan |
Kalra N.,University of Saskatchewan
Journal of Digital Imaging | Year: 2012
Basky G.,41 111 Research Drive |
Brossart B.,41 111 Research Drive |
Smadu M.,Quality and Transformation
Healthcare Management Forum | Year: 2012
Saskatchewan was the first province in Canada to establish a Quality Council. Fall 2012 would mark the 10-year anniversary of this unique change agency. This article looks back on what the Health Quality Council has achieved to date working collaboratively with its health system partners and looks ahead to coming challenges and opportunities. © 2012 Canadian College of Health Leaders.
Klomp H.,41 111 Research Drive |
Dyck R.F.,University of Saskatchewan |
Sidhu N.,41 111 Research Drive |
Cascagnette P.J.,41 111 Research Drive |
And 2 more authors.
BMC Research Notes | Year: 2010
Background: Chronic complications of diabetes can be reduced through optimal glycemic and lipid control as evaluated through measurement of glycosylated hemoglobin (A1C) and low-density lipoprotein cholesterol (LDL-C). We aimed to produce measures of quality of diabetes care in Saskatchewan and to identify sub-groups at particular risk of developing complications. Findings: Prevalent adult cases of diabetes in 2005/06 were identified from administrative databases and linked with A1C and LDL-C tests measured in centralized laboratories. A1C results were performed in 33,927 of 50,713 (66.9%) diabetes cases identified in Saskatchewan, and LDL-C results were performed in 12,031 of 24,207 (49.7%) cases identified within the province's two largest health regions. The target A1C of <= 7.0% and the target LDL-C of <2.5 mmol/L were achieved in 48.3% and 45.1% of diabetes cases respectively. The proportions were lower among those who were female, First Nations, non-urban, younger and in lower income quintiles. The same groups experienced poorer glycemic control (exception females), and poorer lipid control (exception First Nations people). Among non-Aboriginal people, younger diabetic females were least likely to receive lipid lowering agents. Conclusions: Linkage of laboratory with administrative data is an effective method of assessing quality of diabetes care on a population basis and to identify sub-groups requiring particular attention. We found that less than 50% of Saskatchewan people with diabetes achieved optimal glycemic and lipid control. Disparities were most evident among First Nations people and young women. The indicators described can be used to provide standardized information that would support quality improvement initiatives. © 2010 Dyck et al; licensee BioMed Central Ltd.